Try our beta test site
9919 studies found for:    INS
Show Display Options
Rank Status Study
1 Completed Topic Insulin Accelerates Wound Healing in Diabetes
Conditions: Diabetes Mellitus;   Wounds
Intervention: Drug: topic cream insulin
2 Completed Regulation of Endogenous Glucose Production by Brain Insulin Action
Condition: Insulin Resistance, Diabetes
Interventions: Drug: Intranasal insulin;   Drug: Intranasal placebo
3 Unknown  The Effect of Central Insulin on Insulin Sensitivity and Energy Metabolism
Condition: Diabetes
Interventions: Drug: central insulin;   Drug: Placebo
4 Recruiting Effects of Intranasal Insulin Administration on Tissue Specific Insulin Sensitivity
Condition: Insulin Resistance
Interventions: Drug: Insulin;   Drug: Placebo;   Radiation: [18F]-FDG with PET-CT;   Drug: Hyperinsulinemic euglycemic clamp
5 Completed Insulin Dose Titration System Using a Short Messaging Service (SMS) Automatically Produced by a Knowledge Matrix
Condition: Diabetes Mellitus, Type 2
Intervention: Other: Insulin dose titration system using a SMS
6 Completed Influence of Brain Insulin Sensitivity on Peripheral Insulin Sensitivity
Condition: Insulin Sensitivity
Interventions: Drug: human insulin as nasal spray;   Drug: Placebo
Conditions: Type 2 Diabetes;   Insulin Resistance;   High Insulin Requirements
Intervention: Drug: U-500 insulin
8 Unknown  Self-management of Type 1 Diabetes Under Functional Insulin Therapy
Conditions: Type 1 Diabetes;   Basal-bolus Multiple-dily Insulin Injections;   Insulin Pump (CSII)
Interventions: Other: Training course to functional insulin therapy;   Other: Usual diabetes management.
9 Completed Pharmacokinetic (PK) Bioequivalence and Pharmacodynamics (PD) of Julphar Insulin 30/70 and Huminsulin® Profil III
Condition: Diabetes Mellitus
Interventions: Drug: human biphasic insulin;   Drug: human biphasic insulin, reference
10 Completed Pharmacokinetic (PK) Bioequivalence and Pharmacodynamics (PD) of Julphar Insulin N and Huminsulin® Basal
Condition: Diabetes Mellitus
Interventions: Drug: Julphar Insulin N (human isophane insulin);   Drug: Huminsulin® Basal (NPH, human isophane insulin)
11 Completed Timing of Meal Insulin Boluses for Optimal Postprandial Glycemic Control in Type 1 Diabetes
Condition: Type 1 Diabetes
Intervention: Other: Insulin
12 Completed A Study of Improved Efficacy, Safety and Compliance to Administer Insulin in Pen vs. Vial and Syringe
Condition: Diabetes
Intervention: Device: Insulin Pen Device
13 Completed Pharmacokinetic (PK) Bioequivalence and Pharmacodynamics of Julphar Insulin R and Huminsulin® Normal
Condition: Diabetes Mellitus
Interventions: Drug: Julphar Insulin R (soluble human insulin, biosimilar);   Drug: Huminsulin® Normal (soluble human insulin, reference)
14 Completed Continuous Glucose Monitoring and Insulin Pump Therapy in Diabetic Gastroparesis
Condition: Diabetic Gastroparesis
Intervention: Device: CGMS and insulin pump
15 Completed Investigation of the Impact of Different Application Volumes of Insulin Aspart in Subjects With Type 1 Diabetes
Condition: Type 1 Diabetes
Intervention: Drug: Insulin aspart
16 Completed A Study to Evaluate the Effect of Nasal Insulin on Postprandial Glycemic Control in Type 2 Diabetic Patients
Condition: Diabetes Mellitus
Interventions: Drug: Insulin (recombinant human insulin);   Drug: NovoLog
17 Completed Changes of the Infusion Rate in Insulin Pump Treatment
Condition: Diabetes
Intervention: Drug: Insulin Aspart
18 Completed Influence of Central Nervous Insulin Action on Insulin Sensitivity of Peripheral Organs in Lean Versus Overweight Humans
Condition: Insulin Resistance
Intervention: Drug: human insulin
19 Unknown  The Effect of a Checklist on the Education of Simulated Patients During Insulin Initiation
Condition: Insulin Checklist
Intervention: Other: Insulin Start-up Checklist
20 Suspended A Two Part Study of Peroral Insulin in Type 2 Diabetes
Condition: Diabetes Mellitus
Intervention: Drug: Insulin in Dextran Matrix

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.